Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GXE:GR

32.300 EUR 0.600 1.82%

As of 11:21:22 ET on 04/24/2015.

Snapshot for Galapagos NV (GXE)

Open: 32.242 Day's Range: 31.330 - 32.600 Volume: 649
Previous Close: 32.900 52wk Range: 10.020 - 33.600 1-Yr Rtn: +105.41%

Stock Chart for GXE

No chart data available.
  • GXE:GR 32.300
  • 1D
  • 1M
  • 1Y
32.900
Interactive GXE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GXE

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 20.2508
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2015) 1.5950
Est. PEG Ratio 0.8805
Market Cap (M EUR) 997.12
Shares Outstanding (M) 30.87
30 Day Average Volume 487
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GXE

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GXE

Galapagos NV is a drug discovery company focused on the identification of disease modifying drug targets. The Company specializes in osteoporosis, rheumatoid arthritis, osteoarthritis and Alzheimer's disease.

Onno Van De StolpeCEO/Executive DirectorBart FiliusChief Financial Officer
Piet WigerinckChief Scientific OfficerAndre HoekemaSenior VP:Corporate Dev
More Company Profile & Key Executives for GXE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil